tiprankstipranks
Trending News
More News >
Decoy Therapeutics (DCOY)
NASDAQ:DCOY
US Market

Decoy Therapeutics (DCOY) Financial Statements

Compare
629 Followers

Decoy Therapeutics Financial Overview

Decoy Therapeutics's market cap is currently $5.81M. The company's EPS TTM is $-6.768; its P/E ratio is -0.02; Decoy Therapeutics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 5.23M
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 5.23M
Operating Income$ -5.73M$ -12.89M$ -31.84M$ -12.81M$ -7.79M
EBITDA$ -5.73M$ -12.88M$ -22.97M$ -12.79M$ -7.59M
Net Income$ -5.58M$ -12.54M$ -31.61M$ -12.77M$ -7.35M
Balance Sheet
Cash & Short-Term Investments$ 2.43M$ 5.90M$ 12.11M$ 29.21M$ 11.12M
Total Assets$ 3.02M$ 6.59M$ 14.65M$ 40.83M$ 24.93M
Total Debt$ 221.87K$ 289.64K$ 0.00$ 0.00$ 477.03K
Net Debt$ -2.21M$ -5.61M$ -12.11M$ -29.21M$ -10.64M
Total Liabilities$ 1.51M$ 1.30M$ 4.27M$ 2.11M$ 2.77M
Stockholders' Equity$ 1.51M$ 5.29M$ 10.38M$ 38.72M$ 22.16M
Cash Flow
Free Cash Flow$ -4.53M$ -12.85M$ -19.10M$ -10.20M$ -10.31M
Operating Cash Flow$ -4.53M$ -12.85M$ -17.60M$ -10.20M$ -10.31M
Investing Cash Flow$ 0.00$ 0.00$ -1.50M$ 0.00$ -2.60K
Financing Cash Flow$ 1.06M$ 6.64M$ 1.99M$ 28.30M$ 17.69M
Currency in USD

Decoy Therapeutics Earnings and Revenue History

Decoy Therapeutics Debt to Assets

Decoy Therapeutics Cash Flow

Decoy Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.